Such a methodology was approached for the label-free electrochemical detection of HIgG at μg/mL levels [126,127] and parathyroid hormone-related protein (PTHrP) cancer biomarker at clinical interest levels (ng/mL) [128], representing a simple biodetection alternative that was then extended to other immuno and DNA detection systems [129]. The gene discussed is PTHLH; the disease is cancer.